Jayamas Medica Industri Stock Annual Yield
| OMED Stock | 166.00 1.00 0.60% |
Jayamas Medica Industri fundamentals help investors to digest information that contributes to Jayamas Medica's financial success or failures. It also enables traders to predict the movement of Jayamas Stock. The fundamental analysis module provides a way to measure Jayamas Medica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jayamas Medica stock.
Jayamas |
Jayamas Medica Industri Company Annual Yield Analysis
Jayamas Medica's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Jayamas Medica Industri has an Annual Yield of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Instruments & Supplies (which currently averages 0.0) industry. This indicator is about the same for all Indonesia stocks average (which is currently at 0.0).
Jayamas Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jayamas Medica's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jayamas Medica could also be used in its relative valuation, which is a method of valuing Jayamas Medica by comparing valuation metrics of similar companies.Jayamas Medica is currently under evaluation in annual yield category among its peers.
Jayamas Fundamentals
| Return On Equity | 0.52 | |||
| Return On Asset | 0.29 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 5.63 T | |||
| Shares Outstanding | 27.06 B | |||
| Shares Owned By Insiders | 8.00 % | |||
| Shares Owned By Institutions | 0.47 % | |||
| Price To Book | 5.55 X | |||
| Price To Sales | 2.76 X | |||
| Revenue | 2.19 T | |||
| Gross Profit | 904.29 B | |||
| EBITDA | 697.78 B | |||
| Net Income | 562.69 B | |||
| Book Value Per Share | 46.00 X | |||
| Cash Flow From Operations | 505.11 B | |||
| Earnings Per Share | 16.47 X | |||
| Number Of Employees | 1.03 K | |||
| Market Capitalization | 5.9 T | |||
| Last Dividend Paid | 10.87 |
About Jayamas Medica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jayamas Medica Industri's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jayamas Medica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jayamas Medica Industri based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.